SCTbio is a leading cGMP manufacturer specialising in the production of cell-based products and advanced therapy medicinal products (ATMPs).

SCTbio is a dynamic biotechnology company dedicated to supporting the development and production of innovative cell therapies and ATMPs. Operating from its state-of-the-art facilities, SCTbio offers a comprehensive range of cGMP manufacturing services tailored to meet the complex needs of clinical and commercial cell therapy programmes. With a commitment to quality, compliance, and innovation, SCTbio enables its clients to bring life-changing therapies to patients efficiently and effectively. The company serves as a strategic partner for biotechnology and pharmaceutical firms, leveraging its expertise and infrastructure to address challenges in scalability, regulatory compliance, and cost-effectiveness.

Key Products and Services

• cGMP Manufacturing Services: High-quality manufacturing for cell-based products and ATMPs, ensuring adherence to stringent regulatory standards.
• Process Development: Customised solutions to optimise cell therapy production processes from early-stage development to commercialisation.
• Quality Control and Analytical Testing: Comprehensive testing to ensure the safety, efficacy, and consistency of products.
• Apheresis Network Access: Connection to a robust network of over 150 apheresis centres for sourcing critical materials.
• Logistics Support: Seamless coordination of material and product transportation to maintain supply chain integrity.
• Regulatory Support: Guidance to navigate complex regulatory pathways, ensuring compliance and facilitating approvals.

SCTbio continues to position itself as a trusted partner in the biotechnology and pharmaceutical sectors, combining technical excellence with a client-centric approach. By providing integrated solutions and leveraging cutting-edge technologies, SCTbio empowers its partners to overcome industry challenges and deliver transformative therapies to patients worldwide. With its unwavering focus on quality and innovation, SCTbio remains at the forefront of cell therapy manufacturing and development.